C Jemma

Isolation of interferon-resistant variants of friend erythroleukemia cells: Effects of interferon and ouabain

Elisabetta Affabris, C Jemma, Giovanni Battista Rossi · Virology · 1982 · 73 citations

Autoimmune Disease, Friend Erythroleukemia Cells, Immunology +5

Obligatory role of IFN- <i>gamma</i> in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.

Mirella Giovarelli, Angela Santoni, C Jemma et al. · The Journal of Immunology · 1988 · 71 citations

Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population

R. Foà, M Giovarelli, C Jemma et al. · Blood · 1985 · 51 citations · Full text

2–5A synthetase activity does not increase in interferon-resistant friend leukemia cell variants treated with α/β interferon despite the presence of high-affinity interferon receptor sites

Elisabetta Affabris, G. Romeo, Filippo Belardelli et al. · Virology · 1983 · 51 citations

Synthetase Activity, Immunology, Antisense Therapy +5

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

G Cortesina, Antonella De Stefani, E Galeazzi et al. · British Journal of Cancer · 1994 · 47 citations · Full text

Cancer Research, High Dose, Medicine +12